Understanding how a diabetes gene affects liver metabolism
The Regulation of Hepatic Metabolic Zonation by the Diabetes Gene TCF7L2
This study is looking at how a specific gene called TCF7L2 affects different areas of the liver that help process nutrients, which could help us understand liver diseases like NASH and improve health for people with diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Science Center NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project ID | NIH-11001945 on NIH RePORTER |
What this research studies
This research investigates the role of the TCF7L2 gene in regulating the liver's metabolic zones, which are crucial for processing nutrients and maintaining metabolic health. By using a specialized mouse model, the study aims to uncover how TCF7L2 influences the functions of liver cells in different zones and how this regulation may contribute to liver diseases like nonalcoholic steatohepatitis (NASH). The research employs a combination of cellular, genomic, and physiological methods to explore these mechanisms, potentially leading to new insights into diabetes and liver health.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are at risk for or have been diagnosed with type 2 diabetes or related liver conditions.
Not a fit: Patients with liver diseases unrelated to metabolic processes or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating liver diseases associated with diabetes.
How similar studies have performed: Previous research has shown promising results in understanding the role of metabolic genes in liver function, suggesting that this approach could yield valuable insights.
Where this research is happening
San Antonio, United States
- University of Texas Hlth Science Center — San Antonio, United States (Active)
Researchers
- Principal investigator: Norton, Luke — University of Texas Hlth Science Center
- Study coordinator: Norton, Luke
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.